Non-neuronal cell modulation relieves neuropathic pain: Efficacy of the endogenous lipid palmitoylethanolamide

CNS and Neurological Disorders - Drug Targets

Volumn 12, Issue 1, 2013, Pages 34-44

  Bettoni, Isabella ^a   Comelli, Francesca ^a   Colombo, Anita ^a   Bonfanti, Patrizia ^a   Costa, Barbara ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Cannabinoid; Mast cell; Microglia; Nerve growth factor; Neuropathic pain; Palmitoylethanolamide; Tumor necrosis factor

Indexed keywords

BRINASE; NERVE GROWTH FACTOR; PALMIDROL; PROTEIN TYROSINE KINASE A;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; HYPERALGESIA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL DEGRANULATION; MICROGLIA; MOUSE; MYELIN SHEATH; NEUROPATHIC PAIN; NONHUMAN; SCIATIC NERVE;

ANALGESICS; ANIMALS; ENDOCANNABINOIDS; ETHANOLAMINES; MALE; MAST CELLS; MICE; MICE, INBRED C57BL; NEURALGIA; PAIN MEASUREMENT; PALMITIC ACIDS; TREATMENT OUTCOME;

EID: 84875353344     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527311312010008     Document Type: Article

References (55)

1. Bachur, N.R.; Masek, K.; Melmon, K.L.; Udenfriend, S. Fatty acid amides of ethanolamine in mammalian tissues. J. Biol. Chem., 1965, 240, 1019-1024.
2. Lambert, D.M.; Vandervoorde, S.; Diependaele, G.; Govaerts, S.J.; Robert, A.R. Anticonvulsant activity of N -palmitoylethanolamide, a putative endocannabinoid, in mice. Epilepsia, 2001, 42, 321-327.
3. Sheerin, A.H.; Zhang, X.; Saucier, D.M.; Corcoran, M.E. Selective antiepileptic effects of N -palmitoylethanolamide, a putative endocannabinoid. Epilepsia, 2004, 45, 1184-1188.
4. Mazzari, S.; Canella, R; Petrelli, L.; Marcolongo, G; Leon, A. N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur. J. Pharmacol, 1996, 300, 227-236.
5. Conti, S.; Costa, B.; Colleoni, M.; Parolaro, D.; Giagnoni G. Antiiflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. Br. J. Pharmacol, 2002, 135, 181-187.
6. Costa, B.; Conti, S.; Giagnoni, G; Colleoni, M. Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems. Br. J. Pharmacol, 2002, 137, 413-420.
7. Calignano, A.; La Rana, G.; Giuffrida, A.; Piomelli, D. Control of pain initiation by endogenous cannabinoids. Nature, 1998, 394, 277-281.
8. Aloe, L.; Leon, A.; Levi-Montalcini, R. A proposed autacoid mechanism controlling mastocyte behaviour. Agents Actions, 1993, 39, C145-C147.
9. Petrosino, S.; Palazzo, E.; de Novellis, V.; Bisogno, T.; Rossi, F.; Maione, S.; Di Marzo, V. Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats. Neuropharmacol, 2007, 52, 415-422.
10. Guasti, L.; Richardson, D.; Jhaveri, M.; Eldeeb, K.; Barrett, D.; Elphick, M.R; Alexander, S.P.; Kendall, D.; Michael, G.J.; Chapman, V. Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain. Mol.Pain., 2009, 5, 35-44.
11. Genovese, T.; Esposito, E.; Mazzon, E.; Di Paola, R.; Meli, R; Bramanti, P.; Piomelli, D.; Calignano, A.; Cuzzocrea, S. Effects of palmitoylethanolamide on signalling pathways implicated in the development of spinal cord injury. JPET, 2008, 326, 12-23.
12. D'Agostino, G; La Rana, G; Russo, R.; Sasso, O.; Iacono, A.; Esposito, E.; Mattace Raso, G; Cuzzocrea, S.; Lo Verme, J.; Piomelli, D.; Meli, R; Calignano, A. Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kB nuclear signalling in dorsal root ganglia. Eur. J. Pharmacol, 2009, 613, 54-59.
13. Lo Verme, J.; Russo, R.; La Rana, G.; Fu, J.; Farthing, J.; Mattace-Raso, G.; Meli, R.; Hohmann, A.; Calignano, A; Piomelli, D. Rapid broad -spectrum analgesia through activation of peroxisome proliferator-activated receptor-a. JPET, 2006, 319, 1051-1061.
14. Costa, B.; Comelli, F.; Bettoni, I.; Colleoni, M.; Giagnoni, G. The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain:involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors. Pain, 2008, 139, 541-550.
15. Calignano, A.; La Rana, G.; Piomelli, D. Anti-nociceptive activity of the endogenous fatty acid amide, palmitoylethanolamide. Eur. J.Pharmacol., 2001, 419, 191-198.
16. Lo Verme, J.; Fu, J.; Astarita, G.; La Rana, G.; Russo, R.; Calignano, A.; Piomelli D. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of Palmitoylethanolamide. Mol. Pharmacol., 2005, 67, 15-19.
17. De Petrocellis, L.; Davis, J.B.; Di Marzo, V. Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors. FEBS Lett., 2001, 506, 253-256.
18. Smart, D.; Jonsson, K.O.; Vandervood, S.; Lambert, D.M.; Fowler, C.J. "Entourage" effects of N-acyl ethanolamines at human vanilloid receptors, Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. Br. J.Pharmacol., 2002, 136, 452-458.
19. Wood, J.D. Visceral pain: spinal afferents, enteric mast cells, enteric nervous system and stress. Curr. Pharm. Des., 2011, 17, 1573-1575.
20. Done, J.D.; Rudick, C.N.; Quick, M.L.; Schaeffer, A.J.; Thumbikat, P. Role of mast cells in male chronic pelvic pain. J. Urol., 2012, 187, 1473-1482.
21. Herbert, M.K.; Just, H.; Schmidt, R.F. Histamine excites groups III and IV afferents from the cat knee joint depending on their resting activity.Neurosci. Lett., 2001, 305, 95-98.
22. Sorkin, L.S.; Xiao, W.H.; Wagner, R.; Myers, R.R. Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience, 1997, 81, 255-262.
23. Leon, A.; Buriani, A.; Dal Toso, R.; Fabris, M.; Romanello, S.; Aloe, L.; Levi-Montalcini, R. Mast cells synthesize, store and release nerve growth factor. Proc. Natl. Acad. Sci. U.S.A., 1994, 91, 3739-3743.
24. Ruiz, G.; Ceballos, D.; Baños, J.E. Behavioral and histological effects of endoneurial administration of nerve growth factor: possible implications in neuropathic pain. Brain Res., 2004, 1011, 1-6.
25. Zuo, Y.; Perkins, N.M.; Tracey, D.J.; Geczy, C.L. Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells. Pain, 2003, 105, 467-479.
26. Horigome, K.; Pryor, J.C.; Bullock, E.D.; Johnson, E.M.Jr. Mediator release from mast cells by nerve growth factor, neurotrophin specificity and receptor mediation. J. Biol. Chem., 1993, 268, 14881-14887.
27. Esposito, E.; Paterniti, I.; Mazzon, E.; Genovese, T.; Di Paola, R.; Galuppo, M.; Cuzzocrea, S. Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury. Brain Behav. Immun., 2011, 25, 1099-1112.
28. Milligan, E.D.; Watkins, L.R. Pathological and protective roles of glia in chronic pain. Nat. Rev. Neurosci., 2009, 10, 23-36.
29. Scholz, J.; Woolf, C.J. The neuropathic pain triad: neurons, immune cells and glia. Nat. Neurosci., 2007, 10, 1361-1368.
30. Skaper, S.D.; Giusti, P.; Facci, L. Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J., 2012, 26, 3103-3117.
31. Zimmermann, M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain, 1983, 16, 109-110.
32. Bennett, G.J.; Xie, Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain, 1988, 33, 87-107.
33. Hargreaves, K.M.; Dubner, R.; Brown, F.; Flores, C.; Joris, J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain, 1988, 32, 77-88.
34. Kawana, S.; Liang, Z.; Nagano, M.; Suzuki, H. Role of substance P in stress-derived degranulation of dermal mast cells in mice. J. Dermatol.Sci., 2006, 42, 47-54.
35. Rozniecki, J.J.; Dimitriadou, V.; Lambracht-Hall, M.; Pang, X.; Theoharides, T.C. Morphological and functional demonstration of rat dura mater mast cell-neuron interactions in vitro and in vivo. Brain Res., 1999, 849, 1-15.
36. Solomon, J.N.; Lewis, C.A.; Ajami, B.; Corbel, S.Y.; Rossi, F.M.; Krieger, G. Origin and distribution of bone marrow-derived cells in the central nervous system in a mouse model of amyotrophic lateral sclerosis. Glia, 2006, 7, 744-753.
37. Tam, S.Y.; Tsai, M.; Yamaguch, M.; Yano, K.; Butterfield, J.K.; Galli, S.J. Expression of functional TrkA receptor tyrosine kinase in the HMC-1 human mast cell line and in human mast cells. Blood, 1997, 90, 1807-1820.
38. De Filippis, D.; Luongo, L.; Cipriano, M.; Palazzo, E.; Cinelli, M.P.; de Novellis, V.; Maione, S.; Iuvone, T. Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats. Mol. Pain., 2011, 10, 7-13.
39. Collington, S.J.; Williams, T.J.; Weller, C.L. Mechanisms underlying the localisation of mast cells in tissues. Trends Immunol., 2011, 32, 478-485.
40. Medic, N.; Vita, F.; Abbate, R.; Soranzo, M.R.; Pacor, S.; Fabbretti, E.; Borelli, V.; Zabucchi, G. Mast cell activation by myelin through scavenger receptor. J. Neuroimmunol., 2008, 200, 27-40.
41. Herzberg, U.; Eliav, E.; Dorsey, J.M.; Gracely, R.H.; Kopin, I.J. NGF involvement in pain induced by chronic constriction injury of the rat sciatic nerve. Neuroreport, 1997, 8, 1613-1618.
42. Li, L.; Xian, C.J.; Zhong, J.H.; Zhou, X.F. Lumbar 5 ventral root transection-induced upregulation of nerve growth factor in sensory neurons and their target tissues: a mechanism in neuropathic pain. Mol. Cell. Neurosci., 2003, 23, 232-250.
43. Ramer, M.S.; Bisby, M.A. Adrenergic innervation of rat sensory ganglia following proximal or distal painful sciatic neuropathy: distinct mechanisms revealed by anti-NGF treatment. Eur. J. Neurosci., 1999, 11, 837-846.
44. Ruiz, G.; Ceballos, D.; Baños, J.E. Behavioral and histological effects of endoneurial administration of nerve growth factor: possible implications in neuropathic pain. Brain. Res., 2004, 1011, 1-6.
45. Tal, M.; Liberman, R. Local injection of nerve growth factor (NGF) triggers degranulation of mast cells in rat paw. Neurosci. Lett., 1997, 221, 129-32.
46. Matsuda, H.; Kannan, Y.; Ushio, H.; Kiso, Y.; Kanemoto, T.; Suzuki, H.; Kitamura, Y. Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells. J. Exp. Med., 1991, 174, 7-14.
47. Sawada, J.; Itakura, A.; Tanaka, A.; Furusaka, T.; Matsuda, H. Nerve growth factor functions as a chemoattractant for mast cells through both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Blood, 2000, 95, 2052-2058.
48. Peleshok, J.C.; Ribeiro-da-Silva, A. Neurotrophic factor changes in the rat thick skin following chronic constriction injury of the sciatic nerve. Mol. Pain., 2012, 8, 1-15.
49. Sugawara, K.; Bíró, T.; Tsuruta, D.; Tóth, B.I.; Kromminga, A.; Zákány, N.; Zimmer, A.; Funk, W.; Gibbs, B.F.; Zimmer, A.; Paus, R. Endocannabinoids limit excessive mast cell maturation and activation in human skin. J. Allergy Clin. Immunol., 2012, 129, 726-738.
50. Facci, L.; Dal Toso, R.; Romanello, S.; Buriani, A.; Skaper, S.D.; Leon, A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. U.S.A., 1995, 92, 3376-3380.
51. Jack, D.B. Aliamides: a new approach to the treatment of inflammation. Drug News and Perspectives, 1996, 9, 93-98.
52. Tsuda, M.; Inoue, K.; Salter, M.W. Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci., 2005, 28, 101-107.
53. Watkins, L.R.; Milligan, E.D.; Maier, S.F. Glial activation: a driving force for pathological pain. Trends Neurosci., 2001, 24, 450-455.
54. Echeverry, S.; Shi, X.Q.; Zhang, J. Characterization of cell proliferation in rat spinal cord following peripheral nerve injury and the relationship with neuropathic pain. Pain, 2008, 135, 37-47.
55. Muccioli, G.G.; Stella, N. Microglia produce and hydrolyze palmitoylethanolamide. Neuropharmacology, 2008, 54, 16-22.